Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Genes harbor clues to addiction, recovery.

Hampton T.

JAMA. 2004 Jul 21;292(3):321-2. No abstract available.

PMID:
15265836
2.

The μ-opioid receptor and treatment response to naltrexone.

Thorsell A.

Alcohol Alcohol. 2013 Jul-Aug;48(4):402-8. doi: 10.1093/alcalc/agt030. Epub 2013 Mar 29. Review.

PMID:
23543091
3.

Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone.

Setiawan E, Pihl RO, Benkelfat C, Leyton M.

Pharmacogenomics. 2012 Jul;13(10):1161-72. doi: 10.2217/pgs.12.99. Review.

PMID:
22909206
4.

The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF.

Alcohol Clin Exp Res. 2012 Mar;36(3):385-94. doi: 10.1111/j.1530-0277.2011.01633.x. Epub 2011 Sep 6. Review.

5.

Pharmacogenetic treatments for drug addiction: alcohol and opiates.

Haile CN, Kosten TA, Kosten TR.

Am J Drug Alcohol Abuse. 2008;34(4):355-81. doi: 10.1080/00952990802122564. Review.

PMID:
18584566
6.

Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.

Ray LA, Chin PF, Miotto K.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):13-22. Review.

PMID:
20201811
7.

Opioid pharmacogenetics of alcohol addiction.

Berrettini W.

Cold Spring Harb Perspect Med. 2013 Jul 1;3(7). pii: a012203. doi: 10.1101/cshperspect.a012203. Review.

8.

Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis.

Chamorro AJ, Marcos M, Mirón-Canelo JA, Pastor I, González-Sarmiento R, Laso FJ.

Addict Biol. 2012 May;17(3):505-12. doi: 10.1111/j.1369-1600.2012.00442.x. Review.

PMID:
22515274
9.

The contribution of genetics to addiction therapy approaches.

Edenberg HJ, Kranzler HR.

Pharmacol Ther. 2005 Oct;108(1):86-93. Review.

PMID:
16026844
10.

The genetics of alcoholism.

Stacey D, Clarke TK, Schumann G.

Curr Psychiatry Rep. 2009 Oct;11(5):364-9. Review.

PMID:
19785977
11.

Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.

Heidbreder CA, Hagan JJ.

Curr Opin Pharmacol. 2005 Feb;5(1):107-18. Review.

PMID:
15661634
12.

COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.

Goldman D, Oroszi G, O'Malley S, Anton R.

J Stud Alcohol Suppl. 2005 Jul;(15):56-64; discussion 33. Review.

PMID:
16223057
13.

Pharmacotherapy of addictions.

Kreek MJ, LaForge KS, Butelman E.

Nat Rev Drug Discov. 2002 Sep;1(9):710-26. Review. Erratum in: Nat Rev Drug Discov 2002 Nov;1(11):920.

PMID:
12209151
14.

Clinical uses of naltrexone: a review of the evidence.

Modesto-Lowe V, Van Kirk J.

Exp Clin Psychopharmacol. 2002 Aug;10(3):213-27. Review.

PMID:
12233982
15.

[Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].

Kato H.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2008 Oct;43(5):697-704. Review. Japanese.

PMID:
19068776
16.

Alcohol addiction and the mu-opioid receptor.

Berrettini W.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:228-33. doi: 10.1016/j.pnpbp.2015.07.011. Epub 2015 Jul 29. Review.

PMID:
26226591
17.

Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone.

Oslin DW, Berrettini WH, O'Brien CP.

Addict Biol. 2006 Sep;11(3-4):397-403. Review.

PMID:
16961767
18.

Opioid antagonists in the treatment of alcohol dependence.

O'Leary G, Borrow J, Weiss RD.

Curr Psychiatry Rep. 2001 Dec;3(6):484-8. Review.

PMID:
11707162
19.

Naltrexone in alcohol dependence.

Hartmann PM.

Am Fam Physician. 1997 Apr;55(5):1877-9, 1883-4. Review.

PMID:
9105212
20.

NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.

Matošić A, Marušić S, Vidrih B, Kovak-Mufić A, Cicin-Šain L.

Acta Clin Croat. 2016 Mar;55(1):134-50. Review.

PMID:
27333729

Supplemental Content

Support Center